Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Income from Discontinued Operations (2025 - 2026)

Updated

Valion Bio (VBIO) posted Income from Discontinued Operations of -$46,000 for Q2 2026, compared with -$256,000 a year earlier.

Analysis

Valion Bio (VBIO) Income from Discontinued Operations (2025 - 2026) Analysis & Trends

For FY2025, Valion Bio's Income from Discontinued Operations came in at -$885,000.

  • In prior years, Valion Bio's Income from Discontinued Operations was -$1.19 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Valion Bio 73,008.00 -25.39 Mn - -46,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46,000.00
Mar 31, 2026 23,000.00
Jun 30, 2025 -256,000.00
Mar 31, 2025 -129,000.00
API Access

Valion Bio Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=VBIO&period=max&api_key=YOUR_API_KEY